Erste Group upgraded Eli Lilly (LLY) to Buy from Hold. The firm sees Lilly gaining market share versus peers and views the company’s first half of 2025 results as “very good.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Insider Sales Surge: Block, Eli Lilly, Strategy, P&G, Dell
- Trump Weekly: Generics to be excluded from pharma tariff plan
- Eli Lilly’s New Diabetes Study: A Potential Game-Changer?
- Eli Lilly’s New Study on Weight Reduction Drugs: A Potential Market Game-Changer?
- Trump Trade: GoodRx, others in talks with White House to join TrumpRx